BioSpace News Archive

Coherus BioSciences, Inc., reviewed corporate events and reported financial results for the quarter ended June 30, 2020.

Revenues increased 21% to $15 million; 72% rise in R&D revenue included a significant contribution from the Takeda biotherapeutics partnership

GW Pharmaceuticals plc, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, announced financial results and operating progress for the second quarter ended June 30, 2020.

Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced that it will present at the Canaccord Genuity 40th Annual Growth Conference and participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the second quarter ended June 30, 2020.

Qualigen Therapeutics, Inc. announced that it will host a business update conference call and live webcast on Tuesday, August 18, 2020 at 4:30 p.m. Eastern time.

Cryoport, Inc., a global leader in life sciences supply chain solutions, announced financial results for Second Quarter and six-month period ended June 30, 2020.

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis, announced financial results for the second quarter ended June 30, 2020.

CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter and six months ended June 30, 2020.

Announces Final Clinical Study Design for IMPALA 2, the Next Phase 3 Study of Molgradex in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)